Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
Jiyun Lee, Joon Ho Shim, Woong-Yang Park, Hee Kyung Kim, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat. 2019;51(1):408-412.   Published online 2018 May 23     DOI: https://doi.org/10.4143/crt.2018.138
Citations to this article as recorded by Crossref logo
Afatinib/gefitinib/osimertinib
Reactions Weekly.2019; 1741(1): 16.     CrossRef
A novel PI3K/mTOR dual inhibitor XH002 exhibited robust antitumor activity in NSCLC
Yuanhao Lv, Tingting Du, Ming Ji, Chunyang Wang, Songwen Lin, Nina Xue, Jing Jin, Heng Xu, Xiaoguang Chen
Journal of Drug Targeting.2018; : 1.     CrossRef